Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

Front Oncol. 2016 Dec 22:6:263. doi: 10.3389/fonc.2016.00263. eCollection 2016.

Author

Charles A Kunos¹

Affiliation

¹ Cancer Therapy Evaluation Program, National Cancer Institute , Bethesda, MD , USA.

No abstract available

Keywords: breast cancer; cervix cancer; ovarian cancer; radiation oncology; stereotactic body radiation therapy; uterine cancer; women’s cancer.

Publication types

Comment